Even low‐dose aspirin inhibits arachidonic acid–induced vasodilation in heart failure
暂无分享,去创建一个
[1] J. McMurray,et al. Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor. , 1999, Hypertension.
[2] J. McMurray,et al. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure. , 1999, Circulation.
[3] F. Barbe,et al. Preserved vasodilator effect of bradykinin in dogs with heart failure. , 1998, Circulation.
[4] A. Cohen-Solal,et al. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. , 1998, Circulation.
[5] N. Ohte,et al. Functional effects of endogenous bradykinin in congestive heart failure. , 1998, Journal of the American College of Cardiology.
[6] D. Webb,et al. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. , 1998, Cardiovascular research.
[7] A. Quyyumi,et al. Aspirin improves endothelial dysfunction in atherosclerosis. , 1998, Circulation.
[8] L S Murray,et al. How reproducible is bilateral forearm plethysmography? , 1998, British journal of clinical pharmacology.
[9] P. Agostoni,et al. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. , 1997, Circulation.
[10] P. Poole‐Wilson,et al. Endothelial control of lower limb blood flow in chronic heart failure. , 1996, Heart.
[11] K. Pritchard,et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. , 1996, Circulation research.
[12] M. Olschewski,et al. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. , 1995, The American journal of cardiology.
[13] P. Vallance,et al. Vasodilatation to arachidonic acid in humans. An insight into endogenous prostanoids and effects of aspirin. , 1995, Circulation.
[14] R. Falk,et al. Is aspirin safe for patients with heart failure? , 1995, British heart journal.
[15] P Vallance,et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. , 1995, Hypertension.
[16] L. Baur,et al. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. , 1995, British heart journal.
[17] N. Arakawa,et al. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.
[18] O. Berg,et al. Inhibition of phospholipase A2 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] A. Smit,et al. Effects of Acetylsalicylic Acid on Peripheral Hemodynamics in Patients with Chronic Heart Failure Treated with Angiotensin‐Converting Enzyme Inhibitors , 1994, Journal of cardiovascular pharmacology.
[20] D. Fitzgerald,et al. Transdermal Modification of Platelet Function A Dermal Aspirin Preparation Selectively Inhibits Platelet Cyclooxygenase and Preserves Prostacyclin Biosynthesis , 1993, Circulation.
[21] W. Rudolph,et al. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. , 1992, Journal of the American College of Cardiology.
[22] A. Takeshita,et al. Endothelium‐Dependent Forearm Vasodilation to Acetylcholine But Not to Substance P Is Impaired in Patients with Heart Failure , 1992, Journal of cardiovascular pharmacology.
[23] G. FitzGerald,et al. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. , 1991, The New England journal of medicine.
[24] T. Rector,et al. Endothelium‐Dependent Vasodilation Is Attenuated in Patients With Heart Failure , 1991, Circulation.
[25] W. Sessa,et al. Arachidonic acid elicits endothelium-dependent release from the rabbit aorta of a constrictor prostanoid resembling prostaglandin endoperoxides. , 1991, Circulation research.
[26] S Senn,et al. Analysis of serial measurements in medical research. , 1990, BMJ.
[27] W. Sessa,et al. Reciprocal Effects of Dexamethasone on Vasodilatory Responses to Arachidonic Acid and Prostanoids in the Isolated Perfused Rabbit Kidney , 1990, Hypertension.
[28] D G Altman,et al. Analysis of serial measurements in medical research. , 1990, BMJ.
[29] J. Ritter,et al. Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. , 1989, British journal of clinical pharmacology.
[30] D. Webb,et al. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. , 1989, The Journal of physiology.
[31] A. Breckenridge,et al. The reproducibility of limb blood flow measurements in human volunteers at rest and after exercise by using mercury-in-Silastic strain gauge plethysmography under standardized conditions. , 1986, Clinical science.
[32] C. Dollery,et al. Effect of vasoactive peptides on prostacyclin synthesis in man , 1986, British journal of pharmacology.
[33] J. Ritter,et al. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man , 1985, Nature.
[34] B. Weksler,et al. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. , 1985, Circulation.
[35] G. FitzGerald,et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.
[36] C. Patrono,et al. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.
[37] S. Heptinstall,et al. DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS , 1981, The Lancet.
[38] R. Abbate,et al. DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN , 1979, The Lancet.
[39] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.